Form D · Pharmaceuticals
Therio, LLC
Manhattan, KS · CIK 0001525523
Offering snapshot reported Aug 30, 2011 · SEC filing
- Reported sold
- $275K Offering amount: $1.2M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jul 5, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 30, 2011 | Initial | $275,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-165160
Source: Form D, filed Aug 30, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Lynn Curtis | Executive |
| Jeffery Lane Curtis | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
8801 Anderson Ave.
Manhattan, KS, 66503
Manhattan, KS, 66503